9,10-dimethyl-1,2-benzanthracene has been researched along with alpha-chymotrypsin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fernandez-del Castillo, C; Graeme-Cook, F; Hartwig, W; Jimenez, RE; Warshaw, AL; Z'graggen, K | 1 |
| Aboudkhil, S; Bouyahya, A; El Antri, S; El Yaagoubi, OM; Filali, H; Lahmadi, A; Samaki, H | 1 |
2 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and alpha-chymotrypsin
| Article | Year |
|---|---|
Immunohistochemical characterization of pancreatic tumors induced by dimethylbenzanthracene in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adenocarcinoma; Aged; Animals; Biomarkers, Tumor; Chromogranin A; Chromogranins; Chymotrypsin; Female; Humans; Immunohistochemistry; Intermediate Filament Proteins; Keratin-20; Keratins; Male; Pancreas; Pancreatic Neoplasms; Precancerous Conditions; Rats; Rats, Sprague-Dawley | 1999 |
Antitumor Effect of
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Caco-2 Cells; Chymotrypsin; Drug Evaluation, Preclinical; Female; Humans; Inula; Mice; Molecular Docking Simulation; Papilloma; Plant Extracts; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Skin Neoplasms; Toxicity Tests | 2021 |